STOCK TITAN

Regional Health Properties Reports Third Quarter 2026 Results

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Regional Health Properties (RHEP) reported third-quarter 2026 revenue of $25.0 million, up 65.2% from the same quarter in 2025. GAAP net loss was $879,000, versus net income of $3.382 million a year earlier. The loss attributable to common shareholders was $0.22 per share, versus earnings of $1.17. Adjusted EBITDA from operations, a non-GAAP earnings measure, rose to $1.150 million from $247,000.

Patient care revenue increased to $14.714 million from $9.831 million, while pharmacy revenue rose to $9.502 million from $4.004 million. Portfolio occupancy reached 76.0% at September 30, versus 67.3% a year earlier. Regional repurchased 15,829 Series B preferred shares below carrying value. At September 30, cash was $1.651 million and net debt carrying value was $42.191 million; stockholders’ deficit was $2.609 million, versus equity of $349,000 at December 31, 2025.

Loading...
Loading translation...
8 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 16 points

How the balance works

Positive

  • Moderate pointThird-quarter revenue increased 65.2% year over year to $25.0 million.
  • Moderate pointAdjusted EBITDA from operations rose to $1.150 million from $247,000 in third-quarter 2025.
  • Moderate pointPortfolio occupancy reached 76.0% at September 30, 2026, versus 67.3% a year earlier.
  • Minor pointPatient care revenue increased to $14.714 million from $9.831 million in third-quarter 2025.
  • Minor pointPharmacy revenue increased to $9.502 million from $4.004 million in third-quarter 2025.
3 minor points
  • Minor pointOperating loss narrowed to $131,000 from $594,000 in third-quarter 2025.
  • Minor pointNet interest expense declined to $576,000 from $751,000 in third-quarter 2025.
  • Minor point15,829 Series B preferred shares were repurchased during the quarter at a discount to carrying value.

Negative

  • Major pointGAAP net loss of $879,000 replaced net income of $3.382 million in third-quarter 2025.
  • Moderate pointCash declined to $1.651 million at September 30, 2026, from $3.013 million at December 31, 2025.
  • Moderate pointStockholders’ deficit reached $2.609 million, versus equity of $349,000 at December 31, 2025.
  • Moderate pointCurrent liabilities of $27.992 million exceeded current assets of $17.978 million at September 30, 2026.
  • Moderate pointDebt net carrying value totaled $42.191 million at September 30, 2026.
  • Moderate pointGeneral and administrative expense rose to $6.570 million from $3.713 million in third-quarter 2025.
  • Moderate pointAssets held for sale impairment totaled $459,000, versus none in third-quarter 2025. 13% of market cap
9 minor points
  • Minor pointCommon-share loss of $0.22 compared with earnings of $1.17 per share in third-quarter 2025.
  • Minor pointRental revenue fell to $798,000 from $1.303 million in third-quarter 2025.
  • Minor pointCost of goods sold increased to $5.838 million from $2.470 million in third-quarter 2025.
  • Minor pointPatient care expense increased to $11.035 million from $8.639 million in third-quarter 2025.
  • Minor pointDepreciation and amortization increased to $785,000 from $547,000 in third-quarter 2025.
  • Minor pointFacility rent expense increased to $248,000 from $197,000 in third-quarter 2025.
  • Minor pointCredit loss expense increased to $210,000 from $166,000 in third-quarter 2025.
  • Minor pointBargain purchase loss of $78,000 compared with a $5.311 million gain in third-quarter 2025.
  • Minor pointAsset disposal loss totaled $11,000, versus none in third-quarter 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
  • Portfolio Occupancy Reached 76%, an 870-Basis-Point Year-Over-Year Improvement
  • Reported revenue of $25.0 million, an increase of 65.2% compared to third quarter 2025
  • Adjusted EBITDA¹ of $1.2 million, an increase of 365% compared to third quarter 2025

ATLANTA, GA, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (the “Company,” “Regional,” “we,” “us” or “our”) (OTCQB: RHEP) (OTCQB: RHEPA) (OTCQB: RHEPB) (OTCQB: RHEPZ), a healthcare company that owns, operates and invests in healthcare real estate and operating businesses focused on long-term care, senior housing and pharmacy services, today announced its financial results for the third quarter ended September 30, 2026.

Third Quarter 2026 Financial Results

  • Reported revenue of $25.0 million, compared with $15.1 million for the third quarter of 2025
  • Reported GAAP net loss of $0.9 million, compared with GAAP net income of $3.7 million for the third quarter of 2025
  • Generated Adjusted EBITDA from operations of $1.2 million, compared with $0.2 million for the third quarter of 2025
  • Reported net loss attributable to common stockholders of $0.22 per share, compared with $1.17 per share for the third quarter of 2025

Third Quarter 2026 Business Highlights

  • Pharmacy Services revenue was $9.5 million following the addition of the Pharmacy Services segment in connection with the SunLink merger
  • Patient care revenues increased to $14.7 million, driven primarily by the transition of facilities to the Healthcare Services segment and higher census across the portfolio
  • Portfolio occupancy was 76.0% at September 30, 2026 vs. 67.3% at September 30, 2025
  • Repurchased 15,829 shares of the Company’s 12.5% Series B Cumulative Redeemable Preferred Shares during the quarter at a discount to carrying value
  • Continued to evaluate refinancing and liquidity alternatives, including potential refinancing of the Southland facility and other mortgage loans

Management Comments

Brent Morrison, Regional’s President, Chief Executive Officer and Chairman, commented, “We are very pleased with our third quarter results, which reflect continued operating improvements and meaningful progress in our transformation from a traditional healthcare real estate landlord into an integrated healthcare company. Our improving financial performance provides growing evidence that our expanded business model is beginning to deliver on its potential. By taking a more active role in facility operations, we are capturing a greater share of the underlying economics of our healthcare assets while creating additional opportunities to improve operational efficiency and profitability.”

Mr. Morrison continued, “While we are encouraged by the operating momentum, we recognize there is more work ahead. Our focus is on improving facility-level profitability, optimizing our Pharmacy and DME operations, and translating stronger operating earnings into sustainable free cash flow. At the same time, we continue to pursue refinancing opportunities that would provide greater financial flexibility to support our operating momentum and strategic growth initiatives.”

1 Adjusted EBITDA is a non-GAAP financial measure. See “Use of Non-GAAP Financial Measures” for important additional information.

Balance Sheet And Liquidity

As of September 30, 2026, the Company had $1.7 million of unrestricted cash and $3.2 million of restricted cash. As of September 30, 2026, the Company had $42.2 million of indebtedness, net of deferred financing costs and unamortized discounts.

About Regional Health Properties, Inc.

Regional Health Properties, Inc. is a healthcare company that owns, operates and invests in healthcare real estate and operating businesses focused on long-term care, senior housing and pharmacy services. For more information, visit https://www.regionalhealthproperties.com.

Important Cautions Regarding Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “expects,” “intends,” “believes,” “anticipates,” “plans,” “likely,” “will,” “seeks,” “estimates” and variations of such words and similar expressions are intended to identify such forward-looking statements. This press release includes forward-looking statements that reflect the Company’s current views with respect to, among other things, its business, operations, financial performance, liquidity, capital resources, refinancing alternatives, facility operations, pharmacy operations, and future strategy.

Forward-looking statements, by their nature, involve estimates, projections, goals, forecasts and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those projected or contemplated by our forward-looking statements due to various factors, including, among others: the operating performance of our Healthcare Services and Pharmacy Services segments; our ability to collect patient, pharmacy and rent receivables; our dependence on the operating success of our tenants and managers; our ability to service our indebtedness and comply with covenants; the availability and cost of capital; our ability to refinance indebtedness, raise capital or complete asset sales on acceptable terms; changes in reimbursement rates and healthcare regulation; pharmacy reimbursement and claims-processing risk; labor costs, staffing availability and union-related matters; regulatory survey and compliance matters; inflation and interest rates; litigation and insurance costs; the relatively illiquid nature of real estate investments; and other factors discussed from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. These forward-looking statements speak only as of the date of this press release, and we expressly disclaim any obligation or undertaking to update or revise any forward-looking statement contained herein, except to the extent otherwise required by applicable law.

Company Contact
Brent Morrison, CFA
Chief Executive Officer & President
Regional Health Properties, Inc.
Tel (678) 368-4402
Brent.morrison@regionalhealthproperties.com


REGIONAL HEALTH PROPERTIES, INC.
STATEMENT OF OPERATIONS
(in thousands)
       
  Three Months Ended September 30, 
  2026  2025 
  (Unaudited)    
Revenues:      
Patient care revenues $14,714  $9,831 
Rental revenues  798   1,303 
Pharmacy revenues  9,502   4,004 
Total revenues  25,014   15,138 
Expenses:        
Cost of goods sold  5,838   2,470 
Patient care expense  11,035   8,639 
Facility rent expense  248   197 
Depreciation and amortization  785   547 
General and administrative expense  6,570   3,713 
Credit loss expense  210   166 
Total expenses, excluding impairment  24,686   15,732 
Impairment loss on assets held for sale  459   — 
Loss from operations  (131)  (594)
Other expense:        
Interest expense, net  576   751 
Loss (gain) on bargain purchase  78   (5,311)
Loss on disposal of assets  11   — 
Other (income) expense, net  83   584 
Total other (income) expense, net  748   (3,976)
Net loss  (879)  3,382 
Deemed contribution related to Preferred Series B purchases  28   278 
Net loss attributable to Regional Health Properties, Inc. common stockholders $(851) $3,660 
Net loss per share of common stock attributable to Regional Health Properties, Inc.:        
Basic and Diluted $(0.22) $1.17 
Weighted average shares of common stock outstanding:        
Basic and Diluted  3,925   3,125 


REGIONAL HEALTH PROPERTIES, INC.
BALANCE SHEET
(in thousands)
       
   9/30/2026   12/31/2025 
   (Unaudited)     
ASSETS        
Cash $1,651  $3,013 
Restricted cash  2,243   1,631 
Accounts receivable, net of allowances of $933 and $727  10,643   8,025 
Inventory  1,464   1,354 
Notes receivable  564   644 
Prepaid expenses and other  1,413   1,623 
Total current assets  17,978   16,290 
Property and equipment, net  35,025   35,805 
Assets held for sale, net  3,811   4,207 
Restricted cash  999   1,420 
Intangible assets  4,584   4,660 
Other assets  3,521   3,842 
Goodwill  1,585   1,585 
Total assets $67,503  $67,809 
LIABILITIES AND EQUITY        
Accounts payable $7,819  $6,986 
Accrued expenses  9,792   7,888 
Other liabilities  2,035   867 
Debt related to assets held for sale, net  3,027   3,001 
Current portion of long term debt  5,319   5,414 
Total current liabilities  27,992   24,156 
Long-term debt, net - less current maturities  33,845   34,738 
Operating lease obligation  2,040   2,325 
Other liabilities  1,544   1,550 
Total liabilities  65,421   62,769 
Preferred stock, Series D, no par values, 1,420 shares authorized; 1,406 shares issued and outstanding at September 30, 2026 and December 31, 2025.  4,691   4,691 
Stockholders' equity:        
Common stock and additional paid-in capital, no par value; 55,000 shares authorized; 3,936 issued and 3,925 outstanding at September 30, 2026 and 3,946 issued and 3,935 outstanding at December 31, 2025.  67,550   67,296 
Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A, Series B and Series D); shares issued and outstanding designated separately        
Preferred stock, Series A, no par value; 560 shares authorized, issued and outstanding at September 30, 2026 and December 31, 2025, with a redemption amount $426 at September 30, 2026 and December 31, 2025  426   426 
Preferred stock, Series B, no par value; 2,812 shares authorized; 1,690 and 1,741 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively, with a redemption amount $13,960 and $14,382 at September 30, 2026 and December 31, 2025, respectively  13,960   14,382 
Accumulated deficit  (84,567)  (81,777)
 Accumulated other comprehensive earnings  22   22 
Total stockholders' equity (deficit)  (2,609)  349 
Total liabilities, Series D preferred stock and stockholders' equity (deficit) $67,503  $67,809 


REGIONAL HEALTH PROPERTIES, INC.
DEBT SUMMARY
(in thousands)
  
           9/30/2026 
   Maturity   Interest Rate   Principal   % of Principal   Deferred financing costs   Unamortized discount on bonds   Net Carrying Value 
                             
Total Fixed Rate Debt  05/29/33   4.35%  36,204   84.3%  (615)  (96)  35,493 
                             
Total Floating Rate Debt  10/01/36   8.67%  6,763   15.7%  (65)  -   6,698 
                             
Total         $42,967   100.0% $(680) $(96) $42,191 


REGIONAL HEALTH PROPERTIES, INC.
RECONCILIATION OF NET (LOSS) TO NON-GAAP FINANCIAL MEASURES
(in thousands)
       
  Three Months Ended September 30, 
  2026  2025 
  (Unaudited)    
       
Net income (loss) $(879) $3,382 
Depreciation and amortization  785   547 
Interest expense, net  576   751 
EBITDA  482   4,680 
Amortization of employee stock compensation  85   124 
Loss (gain) from bargain purchase  78   (5,311)
Loss on disposal of assets  11   0 
Other (income) expense, net  —   584 
Impariment loss on assets held for sale  459   0 
Other one-time income  35   170 
Adjusted EBITDA from operations $1,150  $247 



FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were Regional Health Properties’ third-quarter 2026 earnings results?

Regional Health Properties reported $25.0 million in revenue and a GAAP net loss of $879,000 for the quarter ended September 30, 2026. Revenue increased 65.2% year over year, while the prior-year quarter had net income of $3.382 million. Loss attributable to common shareholders was $0.22 per share.

How much did Regional Health Properties’ occupancy improve in third-quarter 2026?

Portfolio occupancy reached 76.0% at September 30, 2026, compared with 67.3% at September 30, 2025. That represented an 870-basis-point year-over-year improvement.

What refinancing options is Regional Health Properties evaluating?

Regional is evaluating refinancing and liquidity alternatives, including potential refinancing of the Southland facility and other mortgage loans. The company said it is pursuing refinancing opportunities to provide greater financial flexibility; these remain potential transactions rather than completed financing.

What was Regional Health Properties’ fixed-rate and floating-rate debt mix at September 30, 2026?

Fixed-rate debt represented 84.3% of principal, while floating-rate debt represented 15.7%. Fixed-rate principal was $36.204 million with a reported interest rate of 4.35%; floating-rate principal was $6.763 million with a reported interest rate of 8.67%.

Keep reading